As model of IAH, recurrent antecedent treatment with 2-deoxyglucose (2DG) blunted the food intake response to insulin-induced hypoglycemia; yet rodents treated with carvedilol did not develop IAH (i.e., did not exhibit a blunted food intake response to hypoglycemia) (Farhat et al., 2019). The gene discussed is INS; the disease is Hypoglycemia.